Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00581-11
Full Text
Open PDFAbstract
Available in full text
Date
June 16, 2011
Authors
Publisher
American Society for Microbiology